Testmate Health develops rapid, single-use molecular tests to screen for chlamydia and gonorrhoea without a laboratory. The US hospital network Intermountain Health is becoming a shareholder, for an undisclosed amount, and will support clinical validation through to FDA approval.
- Announced on
- Round
- Undisclosed round
- Amount
- Amount not disclosed
- Location
- canton of Vaud
- Sector
- Health & medtech
Investors
- Intermountain Health
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic